Curis CRIS
NASDAQ CRIS
$0.80 -0.03 (-3.61%)
At close: Oct 2, 2026 · 4:00 PM EDT

Curis (CRIS) Gains from Sales and Divestitures (2011 - 2020)

Updated

Curis' Gains from Sales and Divestitures came in at $27.2 million for FY2025.

Analysis

Curis (CRIS) Gains from Sales and Divestitures (2011 - 2020) Analysis & Trends

Going back to FY2009, Curis' Gains from Sales and Divestitures data covers 9 years.

  • The FY2025 figure represents the highest annual Gains from Sales and Divestitures in data going back to FY2009.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Curis 1.56 Mn -32.63 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 -24,000.00
Dec 31, 2019 -21,000.00
Sep 30, 2019 -1,000.00
Jun 30, 2019 -2,000.00
Mar 31, 2019 -5,000.00
Dec 31, 2018 -7,000.00
Dec 31, 2015 5,000.00
Sep 30, 2015 1,000.00
Jun 30, 2015 18,240.00
Mar 31, 2015 -2,240.00
Dec 31, 2014 250.00
Dec 31, 2011 17,417.00
Sep 30, 2011 23,205.00
Jun 30, 2011 5,221.00
Mar 31, 2011 31,225.00
API Access

Curis Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=CRIS&period=max&api_key=YOUR_API_KEY